Search research articles
Contact Us
Filters
Showing results (141-150 of 189) with videos related to
Page
of 19
Sort By:
Cancer
|
March 15, 1991
The effects of 13-cis-retinoic acid and beta-carotene on cellular immunity in humans
R H Prabhala, H S Garewal, M J Hicks, et al.
Clinical Neuropathology
|
March 1, 1993
Symptomatic choroid plexus xanthogranuloma of the lateral ventricle. Case report and brief critical review of xanthogranulomatous lesions of the brain
M J Hicks, S Albrecht, T Trask, et al.
Head & Neck
|
March 1, 1995
Histocytologic grading of mucoepidermoid carcinoma of major salivary glands in prognosis and survival: a clinicopathologic and flow cytometric investigation
M J Hicks, A K el-Naggar, C M Flaitz, et al.
The Journal of Experimental Medicine
|
January 6, 2000
P-Selectin or intercellular adhesion molecule (ICAM)-1 deficiency substantially protects against atherosclerosis in apolipoprotein E-deficient mice
R G Collins, R Velji, N V Guevara, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
April 20, 2004
Liposomal enhancement of the antitumor activity of conditionally replication-competent adenoviral plasmids
Patricia Yotnda, A R Davis, M J Hicks, et al.
Ultrastructural Pathology
|
July 1, 1995
Primary intraoral epithelioid hemangioendothelioma presenting in childhood: review of the literature and case report
C M Flaitz, R K McDaniel, B Mackay, et al.
Gynecologic Oncology
|
January 1, 1989
DNA ploidy, grade, and stage in prognosis of uterine cervical cancer
J R Davis, S Aristizabal, D L Way, et al.
Experimental Cell Research
|
November 22, 2001
The p38 SAPK pathway regulates the expression of the MMP-9 collagenase via AP-1-dependent promoter activation
C Simon, M Simon, G Vucelic, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 15, 1997
Intercellular adhesion molecule-1 deficiency protects MRL/MpJ-Fas(lpr) mice from early lethality
D C Bullard, P D King, M J Hicks, et al.
Cancer Gene Therapy
|
December 17, 2011
Immunotherapy targeting HER2 with genetically modified T cells eliminates tumor-initiating cells in osteosarcoma
N Rainusso, V S Brawley, A Ghazi, et al.
Page
of 19
Search research articles
Search
Showing results (141-150 of 189) with videos related to
Sort By:
Page
of 19
Cancer
|
March 15, 1991
The effects of 13-cis-retinoic acid and beta-carotene on cellular immunity in humans
R H Prabhala, H S Garewal, M J Hicks, et al.
Clinical Neuropathology
|
March 1, 1993
Symptomatic choroid plexus xanthogranuloma of the lateral ventricle. Case report and brief critical review of xanthogranulomatous lesions of the brain
M J Hicks, S Albrecht, T Trask, et al.
Head & Neck
|
March 1, 1995
Histocytologic grading of mucoepidermoid carcinoma of major salivary glands in prognosis and survival: a clinicopathologic and flow cytometric investigation
M J Hicks, A K el-Naggar, C M Flaitz, et al.
The Journal of Experimental Medicine
|
January 6, 2000
P-Selectin or intercellular adhesion molecule (ICAM)-1 deficiency substantially protects against atherosclerosis in apolipoprotein E-deficient mice
R G Collins, R Velji, N V Guevara, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
April 20, 2004
Liposomal enhancement of the antitumor activity of conditionally replication-competent adenoviral plasmids
Patricia Yotnda, A R Davis, M J Hicks, et al.
Ultrastructural Pathology
|
July 1, 1995
Primary intraoral epithelioid hemangioendothelioma presenting in childhood: review of the literature and case report
C M Flaitz, R K McDaniel, B Mackay, et al.
Gynecologic Oncology
|
January 1, 1989
DNA ploidy, grade, and stage in prognosis of uterine cervical cancer
J R Davis, S Aristizabal, D L Way, et al.
Experimental Cell Research
|
November 22, 2001
The p38 SAPK pathway regulates the expression of the MMP-9 collagenase via AP-1-dependent promoter activation
C Simon, M Simon, G Vucelic, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 15, 1997
Intercellular adhesion molecule-1 deficiency protects MRL/MpJ-Fas(lpr) mice from early lethality
D C Bullard, P D King, M J Hicks, et al.
Cancer Gene Therapy
|
December 17, 2011
Immunotherapy targeting HER2 with genetically modified T cells eliminates tumor-initiating cells in osteosarcoma
N Rainusso, V S Brawley, A Ghazi, et al.
Page
of 19